- Posted Monday April 23, 2007
TGen Presents Awards to Valley Healthcare Leaders
Scottsdale Healthcare, the Virginia G. Piper Charitable Trust and the Stardust Foundation honored for their collaborative efforts and leadership
SCOTTSDALE, Ariz. (April 23, 2007) - Scottsdale Healthcare's leadership in bringing biomedical research to community residents was recognized April 10 with a Collaborative Spirit Award presented by the Translational Genomics Research Institute (TGen). Awards were also presented to the Virginia G. Piper Charitable Trust and the Stardust Foundation.
"The vital role of collaboration is becoming clearer by the day as we continue to build a biomedical focus in Arizona," said Dr. Jeffrey Trent, President and Scientific Director of TGen. "We recognize and value TGen's partnerships with organizations like Scottsdale Healthcare, the Virginia G. Piper Charitable Trust and the Stardust Foundation. Their collaborative efforts and leadership provide a sterling example of how we can impact patients and ultimately advance medical care."
The Collaborative Spirit Award recognizes Scottsdale Healthcare's drive to establish wider community access to clinical trials and biotech research, including clinical trials of targeted therapies. President and CEO Tom Sadvary accepted the award on behalf of Scottsdale Healthcare. Scottsdale Healthcare and TGen formed a strategic alliance in 2005 in which Scottsdale Healthcare became a clinical research site for TGen, including the home of TGen Clinical Research Services. "The alliance allows molecular and genomic discoveries to reach patients as quickly as possible, benefiting Valley residents first," said Daniel Von Hoff, MD, FACS, TGen Physician-In-Chief and senior investigator and director of the TGen Clinical and Translational Research Division. "Scottsdale Healthcare CEO Tom Sadvary led the way for innovative partnerships and programs that brought Scottsdale Healthcare physicians and medical and technology researchers together to benefit their patients," added Dr. Von Hoff. In addition to TGen, Scottsdale Healthcare's partnerships include the Arizona Cancer Center, International Genomics Consortium, the University of Arizona's College of Nursing, the Arizona State University College of Nursing and ASU Biodesign Institute, among others. "Now a center for clinical research, institutions from around the state come together to translate research as quickly as possible into improved patient care," said Dr. Von Hoff in referring to Scottsdale Healthcare. TGen researchers are housed in the Virginia G. Piper Cancer Center at Scottsdale Healthcare, which also includes the Scottsdale Clinical Research Institute (SCRI). The facility provides support for physicians engaged in clinical research, and for all other research conducted by community physicians and staff at Scottsdale Healthcare.
In addition to the Collaborative Spirit Award, TGen also presented two John S. McCain Leadership Awards. The Virginia G. Piper Charitable Trust and the Stardust Foundation were recognized for their support of Arizona's biosciences and efforts toward advancing individualized medicine.
# # #
About Scottsdale Healthcare
Established in 1962 and governed by a local volunteer board of directors, Scottsdale Healthcare is the not-for-profit parent organization of the Scottsdale Healthcare Shea, Scottsdale Healthcare Osborn and Scottsdale Healthcare Thompson Peak hospitals, the Virginia G. Piper Cancer Center, Scottsdale Clinical Research Institute, Scottsdale Healthcare Home Health Services and Scottsdale Healthcare Community Health Services.
The Translational Genomics Research Institute (TGen), a non-profit 501(c)(3) organization, with a focus on developing earlier diagnoses and smarter treatments. Translational genomics research is a relatively new field employing innovative advances arising from the Human Genome Project and applying them to the development of diagnostics, prognostics and therapies for cancer, neurological disorders, diabetes and other complex diseases. TGen bases its research on personalized medicine and the institute plans to accomplish its goals through robust and disease-focused research.
Amy Erickson, TGen